BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6289941)

  • 1. Biochemical correlates of the differential sensitivity of subtypes of human leukemia to deoxyadenosine and deoxycoformycin.
    Matsumoto SS; Yu AL; Bleeker LC; Bakay B; Kung FH; Nyhan WL
    Blood; 1982 Nov; 60(5):1096-102. PubMed ID: 6289941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
    Yu AL; Bakay B; Kung FH; Nyhan WL
    Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential sensitivity of leukemic cells to growth inhibition by deoxyadenosine and deoxycoformycin.
    Tanaka M; Kimura K
    Tohoku J Exp Med; 1985 Dec; 147(4):331-41. PubMed ID: 3879563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
    Kurtzberg J; Hershfield MS
    Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine.
    Hershfield MS; Kredich NM; Koller CA; Mitchell BS; Kurtzberg J; Kinney TR; Falletta JM
    Cancer Res; 1983 Jul; 43(7):3451-8. PubMed ID: 6601986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of 2'-deoxycoformycin, adenosine, and deoxyadenosine in patients with acute lymphoblastic leukemia.
    Venner PM; Glazer RI; Blatt J; Sallan S; Rivera G; Holcenberg JS; Lipton J; Murphy SB; Poplack DG
    Cancer Res; 1981 Nov; 41(11 Pt 1):4508-11. PubMed ID: 6975654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes.
    Ratech H; Kim J; Asofsky R; Thorbecke GJ; Hirschhorn R
    J Immunol; 1984 Jun; 132(6):3077-84. PubMed ID: 6202772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of differentiation of human myeloid leukemia cells by 2'-deoxycoformycin in combination with 2'-deoxyadenosine.
    Niitsu N; Umeda M; Honma Y
    Biochem Biophys Res Commun; 1997 Sep; 238(1):100-6. PubMed ID: 9299460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of three T-lymphoid cell lines with distinct sensitivities to deoxyadenosine plus deoxycoformycin.
    Duan DS; Smith W; Sadée W; Cowan MJ
    Thymus; 1992 Feb; 19(1):1-11. PubMed ID: 1373528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxycoformycin-induced response in chronic lymphocytic leukaemia: deoxyadenosine toxicity in non-replicating lymphocytes.
    Kefford RF; Fox RM
    Br J Haematol; 1982 Apr; 50(4):627-36. PubMed ID: 6978147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes.
    Seto S; Carrera CJ; Wasson DB; Carson DA
    J Immunol; 1986 Apr; 136(8):2839-43. PubMed ID: 2870121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consequences of adenosine deaminase deficiency on thymocyte metabolism.
    Thuillier L; Garreau F; Cartier PH
    Eur J Immunol; 1981 Oct; 11(10):788-94. PubMed ID: 6975717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of pokeweed mitogen-stimulated B cells to inhibition by deoxyadenosine.
    Hayward AR
    Clin Exp Immunol; 1980 Jul; 41(1):141-9. PubMed ID: 6969149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deoxyribonucleoside triphosphate accumulation by leukemic cells.
    Mitchell BS; Edwards NL; Koller CA
    Blood; 1983 Aug; 62(2):419-24. PubMed ID: 6603241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of DNA strand breaks in chronic lymphocytic leukemia following treatment with 2'-deoxycoformycin in vivo and in vitro.
    Begleiter A; Glazer RI; Israels LG; Pugh L; Johnston JB
    Cancer Res; 1987 May; 47(9):2498-503. PubMed ID: 3494509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical studies on deoxycoformycin and deoxyadenosine as pharmacologic T cell purging tools.
    Sheridan W; Gordon DS; Fullen AJ; Olson A; Vogler WR; Winton E
    Bone Marrow Transplant; 1989 Sep; 4(5):511-7. PubMed ID: 2790329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme activities of leukemic cells and biochemical changes induced by deoxycoformycin in vitro--lack of correlation with clinical response.
    Ho AD; Ganeshaguru K; Knauf W; Dietz G; Trede I; Hoffbrand AV; Hunstein W
    Leuk Res; 1989; 13(4):269-78. PubMed ID: 2785618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of deoxycoformycin and deoxyadenosine on deoxyribonucleotide concentrations in leukaemic cells.
    Sylwestrowicz T; Piga A; Murphy P; Ganeshaguru K; Russell NH; Prentice HG; Hoffbrand AV
    Br J Haematol; 1982 Aug; 51(4):623-30. PubMed ID: 6980665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools.
    Ross DD; Akman SA; Schrecker AW; Bachur NR
    Cancer Res; 1981 Nov; 41(11 Pt 1):4493-8. PubMed ID: 6975653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of leukemic human null lymphocytes to deoxynucleosides.
    Fox RM; Tripp EH; Piddington SK; Tattersall MH
    Cancer Res; 1980 Sep; 40(9):3383-6. PubMed ID: 6253063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.